EVA

Ireland's Department of Agriculture, Food and the Marine (DAFM) has obtained permission to import the Arvac vaccine ahead of the 2025 breeding season, the European Federation of Thoroughbred Breeders' Associations (EFTBA) announced on Monday. The manufacturing failure of the Artervac vaccine in 2023 had left Europe's elite stallions vulnerable to an outbreak of EVA, a notifiable disease which can cause infertility, as well as pregnancy loss in mares. The EFTBA and its members, including Ireland, France and Germany, had lobbied the EU for permission to import the alternative vaccine, Arvac,...

The European Federation of Thoroughbred Breeders' Association held its series of Autumn Meetings at the John Lambton Rooms, National Horse Racing Museum in Newmarket Nov. 23. A number of matters were discussed at the Autumn Meeting, including the need for an emergency import license for the Equine Viral Arteritis vaccine, known as ARVAC to be granted for Europe's breeding nations. Agreeing to show its support for applications by our country members, the objective is to ensure ARVAC is made available for the start of the 2024 thoroughbred breeding season. EFTBA...

Trainer Archie Watson's runners will not compete at racecourses for at least two weeks after a horse was found to be positive for Equine Viral Arteritis (EVA) antibodies before an intended trip to France. Watson withdrew a trio of UK runners from races on Saturday and another runner from Southwell on Sunday. Horses infected with the virus are typically asymptomatic, but can display a fever, and conjunctivitis among other symptoms. "We recently had a horse undergo routine testing for transit to France as part of the new export testing protocols,"...